Nutex Health (NUTX)
(Delayed Data from NSDQ)
$0.54 USD
0.00 (-0.68%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $0.56 +0.02 (3.84%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NUTX 0.54 0.00(-0.68%)
Will NUTX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for NUTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUTX
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates
NUTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates
Agiliti (AGTI) Q2 Earnings Lag Estimates
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
Other News for NUTX
12 Health Care Stocks Moving In Wednesday's After-Market Session
Why Calavo Growers Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.
Nutex Health receives Nasdaq delisting notification
Nutex Health price target lowered by $1 at Benchmark, here's why